selected publications
- A pilot study treatment of malignant tumors using low-dose 18F-fluorodeoxyglucose (18F-FDG). American journal of nuclear medicine and molecular imaging. 2020 Academic Article GET IT
-
CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response.
Proceedings of the National Academy of Sciences of the United States of America.
2020
Academic Article
GET IT
Times cited: 92 -
Clinicopathological Features of Gastroesophageal Neuroendocrine Neoplasms.
Current gastroenterology reports.
2020
Review
GET IT
Times cited: 1 -
Phase I Study of Epigenetic Priming with Azacitidine Prior to Standard Neoadjuvant Chemotherapy for Patients with Resectable Gastric and Esophageal Adenocarcinoma: Evidence of Tumor Hypomethylation as an Indicator of Major Histopathologic Response.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2016
Academic Article
GET IT
Times cited: 43 -
A phase 2 study of dalantercept, an activin receptor-like kinase-1 ligand trap, in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Cancer.
2016
Academic Article
GET IT
Times cited: 23 -
Chemotherapy dose intensity predicted by baseline nutrition assessment in gastrointestinal malignancies: A multicentre analysis.
European journal of cancer (Oxford, England : 1990).
2016
Academic Article
GET IT
Times cited: 33 -
The role of ¹⁸F-FDG PET imaging in upper gastrointestinal malignancies.
Current treatment options in oncology.
2014
Review
GET IT
Times cited: 11 -
Capecitabine in the treatment of esophageal and gastric cancers.
Expert opinion on investigational drugs.
2013
Review
GET IT
Times cited: 11 -
Met, IGF1R, and other new targets in upper GI malignancies.
Current treatment options in oncology.
2013
Academic Article
GET IT
Times cited: 2 -
High-grade KIT-negative sarcoma of the small bowel in a patient with chronic myeloid leukemia receiving long-term tyrosine kinase inhibitors.
2013
GET IT
Times cited: 1 -
Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2008
Academic Article
GET IT
Times cited: 431 -
Phase II study of uracil-tegafur with leucovorin in elderly (> or = 75 years old) patients with colorectal cancer: ECOG 1299.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2007
Academic Article
GET IT
Times cited: 30